Novel male contraceptives — hormonal or non-hormonal? A summary of research and new developments
Will Jackson reports on novel male contraceptives research developments, covering associated benefits and drawbacks.
medicine
Continue reading
CRISPR? That was so last year: Introducing the Bridge recombinase mechanism
Louise Martin reports on the novel genetic editing technique, the bridge recombinase mechanism, which may outshine CRISPR.
First US bird flu death: Pandemic precursor or viral commotion?
Adam Grassly reports on the recent outbreak of bird flu and measures that can be taken to prevent future pandemics.
Timing is everything: The power of chronotherapy
Leah Fogarty explores the clinical potential of chronotherapy, where treatment is optimised based on the time of day.
Hidden talent turned scientific superpower: The woman who can smell Parkinson’s
Corenna Twiss reflects on the story of Joy Milne, the woman who can smell Parkinson’s Disease, and the potential implications.
Our false sense of security in our immunity
Kayomavua Akpobaro explores how our immune system declines with age and the evolutionary explanation underlying this.
Healing through innovation: An interview with Ariana Adjani
Shanaé Fuller interviews Ariana Adjani, an Oxford alumna and co-founder of Fine Treatment, regarding all things innovative in healthcare.
Guardians turned adversaries – the paradox of cancer immunity
Waywen Loh discusses how the immune system can fight cancer and where it fails and explores how immunity can be leveraged to treat cancer.
Tripping at the final hurdle: Is FDA rejection a setback for psychedelics?
Millicent Crewe discusses the recent rejection of MDMA-assisted therapy for PTSD and the impact on the world of therapy and psychedelics.
Scientists must adapt to our low-trust world
Satchel Walton reflects on why some people struggle to trust scientists in an ever-politicised field and how scientists should boost trust.